Fecal transplantation for the treatment of Clostridium difficile-associated disease or ulcerative colitis

 

Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP).

Fecal transplantation for the treatment of Clostridium difficile-associated disease or ulcerative colitis examines the clinical research evidence on the safety and effects of fecal transplantation in the treatment of patients with Clostridium difficile-associated disease and/or ulcerative colitis. It also provides information on the prevalence and incidence of the two diseases and the availability of fecal transplantation procedure in Alberta and Canada. The Institute of Health Economics prepared this STE report at the request of the Government of Alberta as part of the Institute’s ongoing work to support the Alberta Health Technologies Decision Process.

Information Specialist: Diane Lorenzetti

Publication Type: Health Technology Assessments /
Systematic Reviews

Year of Publication: 2011

Topics: Chronic Diseases / Disorders, Infectious Diseases, Therapy

Authors: Bing Guo, Christa Harstall, Thanh Nguyen, Arto Ohinmaa

ISBN (online): 978-1-926929-01-9

INAHTA URL: http://www.inahta.org/upload/2011/11126_Fecal Transplantation for the Treatment of Clostridium difficle-associated Disease or Ulcerative Colitis.pdf